Comparison of Minoxidil Sulfotransferase Activity Between Scalp Hair, Eyebrows, and Eyelashes: Implication for Minoxidil Efficacy for Off-Label Use
April 2024
in “Journal of cosmetic dermatology”
TLDR Minoxidil is less effective on eyebrows and eyelashes than scalp hair because these areas have lower enzyme activity needed to activate the drug.
The study investigated the activity of the enzyme SULT1A1, which activates minoxidil, a drug used for hair growth, in scalp hair, eyebrows, and eyelashes. The study involved eight patients and used the Minoxidil Response Test to assess SULT1A1 activity. The mean SULT1A1 enzyme activities in eyebrow, eyelash, and scalp hair follicles were 0.1355, 0.0392, and 0.5048, respectively. The study found that SULT1A1 activity in eyelash and eyebrow hair follicles is significantly lower than scalp hair follicles. This suggests that for minoxidil to be effective in these areas, it may be necessary to supplement eyebrow and eyelash hair follicles with sulfotransferase enzymes. However, the use of minoxidil on the face should be approached with caution due to potential side effects. The study is limited by its small sample size.
View this study on onlinelibrary.wiley.com →
Cited in this study
research Eyebrow and Eyelash Alopecia: A Clinical Review
The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.
research Coming full circle (almost): Low dose oral minoxidil for alopecia
Low-dose oral minoxidil is an effective and safe treatment for hair loss.
research Minoxidil Sulfotransferase Enzyme (SULT1A1) genetic variants predicts response to oral minoxidil treatment for female pattern hair loss
Genetic variants affect minoxidil hair loss treatment success.
research Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia
Sulfotransferase in hair follicles helps predict how well minoxidil works for female hair loss.
research Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia
New test predicts if hair loss treatment will work.
research A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men
New 5% minoxidil foam effectively promotes hair growth and is safe for use.
Related
research Safety and efficacy of Trimax‐360 serum in healthy adult subjects with mild to moderate alopecia of scalp
Trimax-360 Serum, when used for 98 days, safely and effectively improves hair growth, thickness, and density without any side effects.
research EVALUATION OF THE EFFECT OF TOPICALLY APPLIED METHYLSULFONYLMETHANE AND THEIR COMBINATION WITH MINOXIDIL SOLUTION FOR IMPROVEMENT OF HAIR GROWTH IN MALE MICE
research 한약재 혼합추출물이 생쥐 탈모 모델의 모발성장 촉진에 미치는 영향
research Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women
Minoxidil works better for female hair loss than alfatradiol, both safe.
research A quantitative hair growth assessment in androgenetic alopecia after application of two cosmetic lotions versus 2% topical minoxidil
Two cosmetic lotions improved hair growth and had better cosmetic effects than 2% minoxidil.
research Topical minoxidil in male pattern baldness: Effects of discontinuation of treatment
Stopping minoxidil treatment resumes balding; continuous use needed for results.